Joint associations of peripheral artery disease and accelerometry-based physical activity with mortality: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL).


Journal

Atherosclerosis
ISSN: 1879-1484
Titre abrégé: Atherosclerosis
Pays: Ireland
ID NLM: 0242543

Informations de publication

Date de publication:
04 2022
Historique:
received: 13 10 2021
revised: 15 02 2022
accepted: 03 03 2022
pubmed: 26 3 2022
medline: 14 4 2022
entrez: 25 3 2022
Statut: ppublish

Résumé

Peripheral artery disease (PAD) and lower levels of physical activity are both associated with higher mortality. Yet, their joint prognostic impact has not been systematically examined, especially in Hispanics/Latinos, and with objective measures. We aimed to examine the joint associations of PAD and physical activity with mortality in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). We studied 7,620 Hispanic/Latino adults aged 45-74 years at baseline (2008-2011) who underwent assessment of PAD with ankle-brachial index (ABI) and physical activity with hip-worn accelerometry. We calculated four physical activity measures: sedentary time, light activity, moderate/vigorous activity, and total activity counts. We quantified the relationship between ABI and mortality overall, and by tertiles of activity measures in restricted cubic splines, using multivariable Cox models accounting for sampling weights. We also assessed cross-categories of ABI and activity measures with mortality. During a median follow up of 7.1 years, 314 participants died. We observed a U-shaped association of ABI with mortality overall (e.g., hazard ratio 1.80 [95%CI 1.20-2.80] at ABI 0.7 vs 1.2). This U-shaped association was generally consistent after stratifying by activity measures, but an elevated mortality risk for higher ABI was not evident in the most active tertile based on sedentary time, time in light activity, and total activity counts. In the cross-category analysis of ABI and physical activity, the highest mortality risk was consistently seen in abnormal ABI (≤0.9 or >1.4) plus the least active tertile (e.g., HR 5.61 [3.31-9.51] for light activity), compared to referent ABI (0.9-1.4) plus the other more active two tertiles, with no interactions between ABI and activity measure. Abnormal ABI and lower accelerometry-based physical activity were independently and jointly associated with mortality in Hispanics, suggesting the importance of simultaneously evaluating leg vascular condition and physical activity.

Sections du résumé

BACKGROUND AND AIMS
Peripheral artery disease (PAD) and lower levels of physical activity are both associated with higher mortality. Yet, their joint prognostic impact has not been systematically examined, especially in Hispanics/Latinos, and with objective measures. We aimed to examine the joint associations of PAD and physical activity with mortality in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
METHODS
We studied 7,620 Hispanic/Latino adults aged 45-74 years at baseline (2008-2011) who underwent assessment of PAD with ankle-brachial index (ABI) and physical activity with hip-worn accelerometry. We calculated four physical activity measures: sedentary time, light activity, moderate/vigorous activity, and total activity counts. We quantified the relationship between ABI and mortality overall, and by tertiles of activity measures in restricted cubic splines, using multivariable Cox models accounting for sampling weights. We also assessed cross-categories of ABI and activity measures with mortality.
RESULTS
During a median follow up of 7.1 years, 314 participants died. We observed a U-shaped association of ABI with mortality overall (e.g., hazard ratio 1.80 [95%CI 1.20-2.80] at ABI 0.7 vs 1.2). This U-shaped association was generally consistent after stratifying by activity measures, but an elevated mortality risk for higher ABI was not evident in the most active tertile based on sedentary time, time in light activity, and total activity counts. In the cross-category analysis of ABI and physical activity, the highest mortality risk was consistently seen in abnormal ABI (≤0.9 or >1.4) plus the least active tertile (e.g., HR 5.61 [3.31-9.51] for light activity), compared to referent ABI (0.9-1.4) plus the other more active two tertiles, with no interactions between ABI and activity measure.
CONCLUSIONS
Abnormal ABI and lower accelerometry-based physical activity were independently and jointly associated with mortality in Hispanics, suggesting the importance of simultaneously evaluating leg vascular condition and physical activity.

Identifiants

pubmed: 35334347
pii: S0021-9150(22)00128-9
doi: 10.1016/j.atherosclerosis.2022.03.008
pmc: PMC9014557
mid: NIHMS1791898
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-62

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL146132
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC65236
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC65235
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC65234
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC65233
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC65237
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020541
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002556
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Références

Ann Epidemiol. 2010 Aug;20(8):642-9
pubmed: 20609344
Eur J Vasc Endovasc Surg. 2008 Jun;35(6):709-14
pubmed: 18313338
Circulation. 2006 Jul 18;114(3):242-8
pubmed: 16818814
J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350
pubmed: 30423393
Ann Behav Med. 2018 Jan 05;52(1):88-92
pubmed: 29538623
Circulation. 2004 Feb 17;109(6):733-9
pubmed: 14970108
JAMA Intern Med. 2015 Jun;175(6):959-67
pubmed: 25844730
Circulation. 2005 Nov 29;112(22):3501-8
pubmed: 16316971
Diabetes Care. 2010 Jan;33 Suppl 1:S11-61
pubmed: 20042772
Eur J Vasc Endovasc Surg. 2016 Mar;51(3):395-403
pubmed: 26777541
Eur J Vasc Endovasc Surg. 2017 Sep;54(3):370-377
pubmed: 28754427
JAMA. 2008 Jul 9;300(2):197-208
pubmed: 18612117
Curr Obes Rep. 2020 Dec;9(4):571-581
pubmed: 32870465
Circulation. 2017 Mar 21;135(12):e726-e779
pubmed: 27840333
J Vasc Surg. 2008 Nov;48(5):1197-203
pubmed: 18692981
J Am Heart Assoc. 2016 Sep 14;5(9):
pubmed: 27628572
JAMA. 2012 Nov 7;308(17):1775-84
pubmed: 23117778
Eur J Cardiovasc Prev Rehabil. 2008 Jun;15(3):239-46
pubmed: 18525377
Circulation. 1993 Aug;88(2):819-28
pubmed: 8339448
Circulation. 2020 Mar 31;141(13):1113-1115
pubmed: 32223676
Am J Epidemiol. 2016 Dec 1;184(11):806-817
pubmed: 27810857
Am J Prev Med. 2016 Apr;50(4):500-508
pubmed: 26597505
JAMA. 2004 Jul 28;292(4):453-61
pubmed: 15280343
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
Diabetes. 2017 Dec;66(12):3001-3012
pubmed: 28986399
PLoS One. 2014 Oct 15;9(10):e110034
pubmed: 25333969
Circulation. 2000 Sep 12;102(11):1270-5
pubmed: 10982542
Vasc Med. 1996;1(1):65-71
pubmed: 9546918
Lancet. 2017 Dec 16;390(10113):2643-2654
pubmed: 28943267
Med Sci Sports Exerc. 2011 Feb;43(2):357-64
pubmed: 20581716
Ann Epidemiol. 2010 Aug;20(8):629-41
pubmed: 20609343
J Sports Sci. 2011 May;29(8):783-9
pubmed: 21424979
J Vasc Surg. 2008 Jan;47(1):117-22
pubmed: 18178462
J Phys Act Health. 2011 May;8(4):587-91
pubmed: 21597132
Am J Epidemiol. 1986 Jul;124(1):17-27
pubmed: 3521261

Auteurs

Yumin Gao (Y)

Johns Hopkins University, Baltimore, MD, USA.

Simin Hua (S)

Albert Einstein College of Medicine, The Bronx, NY, USA.

Yejin Mok (Y)

Johns Hopkins University, Baltimore, MD, USA.

Maya Salameh (M)

Johns Hopkins University, Baltimore, MD, USA.

Qibin Qi (Q)

Albert Einstein College of Medicine, The Bronx, NY, USA.

Guochong Chen (G)

Albert Einstein College of Medicine, The Bronx, NY, USA.

Jessica Williams-Nguyen (J)

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Mollie Pester (M)

University of Miami, Coral Gables, FL, USA.

Olga Garcia-Bedoya (O)

University of Illinois at Chicago, College of Medicine, Chicago, IL, USA.

Daniela Sotres-Alvarez (D)

University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Martha L Daviglus (ML)

University of Illinois at Chicago, College of Medicine, Chicago, IL, USA.

Yasmin Mossavar-Rahmani (Y)

Albert Einstein College of Medicine, The Bronx, NY, USA.

Jennifer A Schrack (JA)

Johns Hopkins University, Baltimore, MD, USA.

Matthew Allison (M)

University of California San Diego, San Diego, CA, USA.

Robert Kaplan (R)

Albert Einstein College of Medicine, The Bronx, NY, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Kunihiro Matsushita (K)

Johns Hopkins University, Baltimore, MD, USA. Electronic address: kuni.matsushita@jhu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH